These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 6515771)

  • 21. [Therapeutic trial with fucidin in systemic scleroderma].
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowski J; Mozdzanowska K
    Z Hautkr; 1984 Dec; 59(23):1611-9. PubMed ID: 6395525
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [D-Penicillamine effect on collagen synthesis and structural maintenance Red Sirius staining with polarized-light examination. The value of this staining in cases of collagen diseases (author's transl)].
    Pieraggi MT; Bonafe JL
    Ann Pathol; 1982; 2(2):155-7. PubMed ID: 6179525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Scleroderma.
    Asboe-Hansen G
    J Am Acad Dermatol; 1987 Jul; 17(1):102-8. PubMed ID: 3611439
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Microcirculatory disorders in systemic scleroderma treated with d-penicillamine].
    Nasonova VA; Alekberova ZS; Mach ES; Balabanova RM
    Klin Med (Mosk); 1981 Nov; 59(11):57-61. PubMed ID: 7321499
    [No Abstract]   [Full Text] [Related]  

  • 25. [Therapy of progressive scleroderma. Collagen-like protein in progressive scleroderma under D-penicillamine therapy].
    Kreysel HW; Schlichting H; Kimmig J
    Fortschr Med; 1975 Nov; 93(32):1596-9. PubMed ID: 1220999
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cross-linked elastin and collagen degradation products in the urine of patients with scleroderma.
    Stone PJ; Korn JH; North H; Lally EV; Miller LC; Tucker LB; Strongwater S; Snider GL; Franzblau C
    Arthritis Rheum; 1995 Apr; 38(4):517-24. PubMed ID: 7718005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of penicillamine on human collagen and its possible application to treatment of scleroderma.
    Harris ED; Sjoerdsma A
    Lancet; 1966 Nov; 2(7471):996-9. PubMed ID: 4162669
    [No Abstract]   [Full Text] [Related]  

  • 28. [Epidemiological study of systemic scleroderma in Tokyo based on application forms for financial aid for patients with intractable diseases].
    Takehara K; Iozumi K; Mori S
    Nihon Hifuka Gakkai Zasshi; 1988 Dec; 98(14):1475-82. PubMed ID: 3251057
    [No Abstract]   [Full Text] [Related]  

  • 29. Changes in serum and urine amino acids in patients with progressive systemic sclerosis treated with 6-azauridine triacetate.
    Slavik M; Lovenberg W; Keiser HR
    Biochem Pharmacol; 1973 Jun; 22(11):1295-300. PubMed ID: 4727783
    [No Abstract]   [Full Text] [Related]  

  • 30. [Effect of unithiol on collagen metabolism in systemic scleroderma].
    Pasieshvili LM
    Vopr Revm; 1980; (1):57-8. PubMed ID: 7385751
    [No Abstract]   [Full Text] [Related]  

  • 31. Systemic sclerosis.
    Pearson ME; Stechschulte DJ
    J Kans Med Soc; 1984 Jan; 85(1):13-7. PubMed ID: 6368712
    [No Abstract]   [Full Text] [Related]  

  • 32. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].
    Alekperov RT; Avdeev SN; Kotovskaia MA
    Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of systemic scleroderma with fucidin in relation to clinical evaluation and analysis of free amino acids in the serum].
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowska K; Mozdzanowski J
    Przegl Dermatol; 1986; 73(4):305-11. PubMed ID: 3333865
    [No Abstract]   [Full Text] [Related]  

  • 34. [Recent attempts at treatment of diffuse scleroderma].
    Pavelka K
    Cas Lek Cesk; 1972; 111(10):221-3. PubMed ID: 5010871
    [No Abstract]   [Full Text] [Related]  

  • 35. Treatment of systemic scleroderma with fucidine with regard to some free amino acids contents before and after therapy.
    Rubisz-Brzezińska J; Zebracka T; Mozdzanowska K; Mozdzanowski J
    Acta Derm Venereol; 1984; 64(3):267-70. PubMed ID: 6204494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. D-penicillamine in progressive scleroderma.
    Lorenzen I; Uitto J; Ohlenschlaeger K
    Scand J Rheumatol; 1972; 1(3):121-4. PubMed ID: 4667928
    [No Abstract]   [Full Text] [Related]  

  • 37. [New developments in the pathology, pathophysiology and therapy of systemic scleroderma].
    Asboe-Hansen G
    Hautarzt; 1980 Nov; 31(11):584-7. PubMed ID: 7451139
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Minimal changes nephrotic syndrome associated to penicillamine treatment].
    Basterrechea MA; de Arriba G; García-Martín F; Sánchez-Heras M; Giménez-Vega E; Sánchez J
    Nefrologia; 2004; 24(2):183-7. PubMed ID: 15219094
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of progressive systemic sclerosis (PSS) with penicillamine. Preliminary report of two cases.
    Tio H; van Wijk L; de Haan E
    Acta Med Scand; 1973 May; 193(5):477-80. PubMed ID: 4717327
    [No Abstract]   [Full Text] [Related]  

  • 40. [Nephropathy in a patient with systemic scleroderma treated with D-penicillamine].
    Balabanova RM; Ivanova MM; Oskilko TG
    Ter Arkh; 1980; 52(4):119-21. PubMed ID: 7404326
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.